LASER LAB COIMBRA
The University of Coimbra’s laser and photonics lab provides training and user access to multiple advanced techniques in optics, bio-imaging, and bio-processing, and is part of Laser Lab Europe.
Red Universitaria Ibero-americana de Incubación de Empresas (RedEmprendia) pursues the valuation and marketing of applied research. In 2010, with the support of Santander, RedEmprendia awarded LaserLeap Tehnologies its research prize in a competitive contest involving prestigious Ibero-American universities. This prize supported the development of prototypes and the establishment of our worldwide patent.
Capital is not enough. Our partner, BUSY Angels, boosts entrepreneurs through its expertise, networking, and experience.
Hovione Capital is a privately held asset management company specializing in the Health sector. As a venture capital investor, we specialize in identifying high-potential early-stage investment opportunities that provide diagnostic, chronic disease monitoring, IT-integration opportunities. The projects Hovione Capital is looking for benefit from patented differentiating technologies, which are directly scalable and address the global market. Leveraging on existing economies of scope, we are particularly interested in information rich m-health and medical device projects that address and provide measurable benefits to patients, caretakers, caregivers, as well as reimbursement and health care systems.
ARMILAR VENTURE PARTNERS
Armilar Venture Partners is a venture capital firm, part the Novo Banco group, with over € 250 million in assets under management and investments in innovative companies all around the world. Armilar Venture Partners supports the top entrepreneurs and invests very selectively in early-stage innovative technologies and business models that best address the pressing global challenges of this century: the environment, demographics, and global development.
LaserLeap Technologies was awarded a research grant from the European Union, through Mais Centro, to further develop and market its patented technology.
LaserLeap Technologies was awarded a research grant from the European Union, through the COMPETE program, to further develop and market its patented technology.